2.4.0.8 Html 101 190 1 false 30 0 false 5 false false R1.htm 000 - Disclosure - Document And Entity Information Sheet http://www.sophirisbio.com/role/DocumentAndEntityInformation Document And Entity Information true false R2.htm 001 - Statement - Condensed Consolidated Balance Sheets (Unaudited) Sheet http://www.sophirisbio.com/role/ConsolidatedBalanceSheet Condensed Consolidated Balance Sheets (Unaudited) false false R3.htm 002 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parentheticals) Sheet http://www.sophirisbio.com/role/ConsolidatedBalanceSheet_Parentheticals Condensed Consolidated Balance Sheets (Unaudited) (Parentheticals) false false R4.htm 003 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) Sheet http://www.sophirisbio.com/role/ConsolidatedIncomeStatement Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) false false R5.htm 004 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://www.sophirisbio.com/role/ConsolidatedCashFlow Condensed Consolidated Statements of Cash Flows (Unaudited) false false R6.htm 005 - Disclosure - Note 1 - Nature of the Business Sheet http://www.sophirisbio.com/role/Note1NatureoftheBusiness Note 1 - Nature of the Business false false R7.htm 006 - Disclosure - Note 2 - Recently Adopted Accounting Pronouncements Sheet http://www.sophirisbio.com/role/Note2RecentlyAdoptedAccountingPronouncements Note 2 - Recently Adopted Accounting Pronouncements false false R8.htm 007 - Disclosure - Note 3 - Summary of Significant Accounting Policies Sheet http://www.sophirisbio.com/role/Note3SummaryofSignificantAccountingPolicies Note 3 - Summary of Significant Accounting Policies false false R9.htm 008 - Disclosure - Note 4 - Net Loss per Common Share Sheet http://www.sophirisbio.com/role/Note4NetLossperCommonShare Note 4 - Net Loss per Common Share false false R10.htm 009 - Disclosure - Note 5 - Securities Available-for-Sale Sheet http://www.sophirisbio.com/role/Note5SecuritiesAvailableforSale Note 5 - Securities Available-for-Sale false false R11.htm 010 - Disclosure - Note 6 - Fair Value Measurement and Financial Instruments Sheet http://www.sophirisbio.com/role/Note6FairValueMeasurementandFinancialInstruments Note 6 - Fair Value Measurement and Financial Instruments false false R12.htm 011 - Disclosure - Note 7 - Prepaid Expenses Sheet http://www.sophirisbio.com/role/Note7PrepaidExpenses Note 7 - Prepaid Expenses false false R13.htm 012 - Disclosure - Note 8 - Accrued Expenses Sheet http://www.sophirisbio.com/role/Note8AccruedExpenses Note 8 - Accrued Expenses false false R14.htm 013 - Disclosure - Note 9 - Promissory Notes Notes http://www.sophirisbio.com/role/Note9PromissoryNotes Note 9 - Promissory Notes false false R15.htm 014 - Disclosure - Note 10 - Common Stock Purchase Agreement with Aspire Capital Sheet http://www.sophirisbio.com/role/Note10CommonStockPurchaseAgreementwithAspireCapital Note 10 - Common Stock Purchase Agreement with Aspire Capital false false R16.htm 015 - Disclosure - Note 11 - Stock-based Compensation Plan Sheet http://www.sophirisbio.com/role/Note11StockbasedCompensationPlan Note 11 - Stock-based Compensation Plan false false R17.htm 016 - Disclosure - Note 12 - Kissei Agreement Sheet http://www.sophirisbio.com/role/Note12KisseiAgreement Note 12 - Kissei Agreement false false R18.htm 017 - Disclosure - Note 13 - Purchase Commitments Sheet http://www.sophirisbio.com/role/Note13PurchaseCommitments Note 13 - Purchase Commitments false false R19.htm 018 - Disclosure - Accounting Policies, by Policy (Policies) Sheet http://www.sophirisbio.com/role/AccountingPoliciesByPolicy Accounting Policies, by Policy (Policies) false false R20.htm 019 - Disclosure - Note 4 - Net Loss per Common Share (Tables) Sheet http://www.sophirisbio.com/role/Note4NetLossperCommonShareTables Note 4 - Net Loss per Common Share (Tables) false false R21.htm 020 - Disclosure - Note 5 - Securities Available-for-Sale (Tables) Sheet http://www.sophirisbio.com/role/Note5SecuritiesAvailableforSaleTables Note 5 - Securities Available-for-Sale (Tables) false false R22.htm 021 - Disclosure - Note 6 - Fair Value Measurement and Financial Instruments (Tables) Sheet http://www.sophirisbio.com/role/Note6FairValueMeasurementandFinancialInstrumentsTables Note 6 - Fair Value Measurement and Financial Instruments (Tables) false false R23.htm 022 - Disclosure - Note 7 - Prepaid Expenses (Tables) Sheet http://www.sophirisbio.com/role/Note7PrepaidExpensesTables Note 7 - Prepaid Expenses (Tables) false false R24.htm 023 - Disclosure - Note 8 - Accrued Expenses (Tables) Sheet http://www.sophirisbio.com/role/Note8AccruedExpensesTables Note 8 - Accrued Expenses (Tables) false false R25.htm 024 - Disclosure - Note 9 - Promissory Notes (Tables) Notes http://www.sophirisbio.com/role/Note9PromissoryNotesTables Note 9 - Promissory Notes (Tables) false false R26.htm 025 - Disclosure - Note 11 - Stock-based Compensation Plan (Tables) Sheet http://www.sophirisbio.com/role/Note11StockbasedCompensationPlanTables Note 11 - Stock-based Compensation Plan (Tables) false false R27.htm 026 - Disclosure - Note 3 - Summary of Significant Accounting Policies (Details) Sheet http://www.sophirisbio.com/role/Note3SummaryofSignificantAccountingPoliciesDetails Note 3 - Summary of Significant Accounting Policies (Details) false false R28.htm 027 - Disclosure - Note 4 - Net Loss per Common Share (Details) - Potentially Dilutive Securities Excluded from Diluted Weighted-Avg. Shares Outstanding Sheet http://www.sophirisbio.com/role/PotentiallyDilutiveSecuritiesExcludedfromDilutedWeightedAvgSharesOutstandingTable Note 4 - Net Loss per Common Share (Details) - Potentially Dilutive Securities Excluded from Diluted Weighted-Avg. Shares Outstanding false false R29.htm 028 - Disclosure - Note 5 - Securities Available-for-Sale (Details) - Securities Available-for-Sale Sheet http://www.sophirisbio.com/role/SecuritiesAvailableforSaleTable Note 5 - Securities Available-for-Sale (Details) - Securities Available-for-Sale false false R30.htm 029 - Disclosure - Note 5 - Securities Available-for-Sale (Details) - Amortized Cost and Estimated Fair Value of Securities Sheet http://www.sophirisbio.com/role/AmortizedCostandEstimatedFairValueofSecuritiesTable Note 5 - Securities Available-for-Sale (Details) - Amortized Cost and Estimated Fair Value of Securities false false R31.htm 030 - Disclosure - Note 6 - Fair Value Measurement and Financial Instruments (Details) Sheet http://www.sophirisbio.com/role/Note6FairValueMeasurementandFinancialInstrumentsDetails Note 6 - Fair Value Measurement and Financial Instruments (Details) false false R32.htm 031 - Disclosure - Note 6 - Fair Value Measurement and Financial Instruments (Details) - Assets and Liabilities Measured at Fair Value Measured on a Recurring Basis Sheet http://www.sophirisbio.com/role/AssetsandLiabilitiesMeasuredatFairValueMeasuredonaRecurringBasisTable Note 6 - Fair Value Measurement and Financial Instruments (Details) - Assets and Liabilities Measured at Fair Value Measured on a Recurring Basis false false R33.htm 032 - Disclosure - Note 6 - Fair Value Measurement and Financial Instruments (Details) - Fair Value Assumptions, Warrant Liability Sheet http://www.sophirisbio.com/role/FairValueAssumptionsWarrantLiabilityTable Note 6 - Fair Value Measurement and Financial Instruments (Details) - Fair Value Assumptions, Warrant Liability false false R34.htm 033 - Disclosure - Note 6 - Fair Value Measurement and Financial Instruments (Details) - Fair Value Assumptions, Stock-based Compensation Liability Sheet http://www.sophirisbio.com/role/FairValueAssumptionsStockbasedCompensationLiabilityTable Note 6 - Fair Value Measurement and Financial Instruments (Details) - Fair Value Assumptions, Stock-based Compensation Liability false false R35.htm 034 - Disclosure - Note 6 - Fair Value Measurement and Financial Instruments (Details) - Fair Value Reconciliation of Warrant Liability Sheet http://www.sophirisbio.com/role/FairValueReconciliationofWarrantLiabilityTable Note 6 - Fair Value Measurement and Financial Instruments (Details) - Fair Value Reconciliation of Warrant Liability false false R36.htm 035 - Disclosure - Note 6 - Fair Value Measurement and Financial Instruments (Details) - Fair Value Reconciliation of Stock-based Compensation Liability Sheet http://www.sophirisbio.com/role/FairValueReconciliationofStockbasedCompensationLiabilityTable Note 6 - Fair Value Measurement and Financial Instruments (Details) - Fair Value Reconciliation of Stock-based Compensation Liability false false R37.htm 036 - Disclosure - Note 7 - Prepaid Expenses (Details) Sheet http://www.sophirisbio.com/role/Note7PrepaidExpensesDetails Note 7 - Prepaid Expenses (Details) false false R38.htm 037 - Disclosure - Note 7 - Prepaid Expenses (Details) - Components of Prepaid Expenses Sheet http://www.sophirisbio.com/role/ComponentsofPrepaidExpensesTable Note 7 - Prepaid Expenses (Details) - Components of Prepaid Expenses false false R39.htm 038 - Disclosure - Note 8 - Accrued Expenses (Details) - Components of Accrued Expenses Sheet http://www.sophirisbio.com/role/ComponentsofAccruedExpensesTable Note 8 - Accrued Expenses (Details) - Components of Accrued Expenses false false R40.htm 039 - Disclosure - Note 9 - Promissory Notes (Details) Notes http://www.sophirisbio.com/role/Note9PromissoryNotesDetails Note 9 - Promissory Notes (Details) false false R41.htm 040 - Disclosure - Note 9 - Promissory Notes (Details) - Future Contractual Principal and Final Fee Payments Notes http://www.sophirisbio.com/role/FutureContractualPrincipalandFinalFeePaymentsTable Note 9 - Promissory Notes (Details) - Future Contractual Principal and Final Fee Payments false false R42.htm 041 - Disclosure - Note 9 - Promissory Notes (Details) - Actual Interest Expense and Amortization of Debt Discount Notes http://www.sophirisbio.com/role/ActualInterestExpenseandAmortizationofDebtDiscountTable Note 9 - Promissory Notes (Details) - Actual Interest Expense and Amortization of Debt Discount false false R43.htm 042 - Disclosure - Note 10 - Common Stock Purchase Agreement with Aspire Capital (Details) Sheet http://www.sophirisbio.com/role/Note10CommonStockPurchaseAgreementwithAspireCapitalDetails Note 10 - Common Stock Purchase Agreement with Aspire Capital (Details) false false R44.htm 043 - Disclosure - Note 11 - Stock-based Compensation Plan (Details) Sheet http://www.sophirisbio.com/role/Note11StockbasedCompensationPlanDetails Note 11 - Stock-based Compensation Plan (Details) false false R45.htm 044 - Disclosure - Note 11 - Stock-based Compensation Plan (Details) - Stock-based Compensation Expense Sheet http://www.sophirisbio.com/role/StockbasedCompensationExpenseTable Note 11 - Stock-based Compensation Plan (Details) - Stock-based Compensation Expense false false R46.htm 045 - Disclosure - Note 11 - Stock-based Compensation Plan (Details) - Fair Value of Options Granted Sheet http://www.sophirisbio.com/role/FairValueofOptionsGrantedTable Note 11 - Stock-based Compensation Plan (Details) - Fair Value of Options Granted false false R47.htm 046 - Disclosure - Note 11 - Stock-based Compensation Plan (Details) - Stock Option Activity Sheet http://www.sophirisbio.com/role/StockOptionActivityTable Note 11 - Stock-based Compensation Plan (Details) - Stock Option Activity false false R48.htm 047 - Disclosure - Note 12 - Kissei Agreement (Details) Sheet http://www.sophirisbio.com/role/Note12KisseiAgreementDetails Note 12 - Kissei Agreement (Details) false false R49.htm 048 - Disclosure - Note 13 - Purchase Commitments (Details) Sheet http://www.sophirisbio.com/role/Note13PurchaseCommitmentsDetails Note 13 - Purchase Commitments (Details) false false All Reports Book All Reports Element sphs_ChangeInFairValueOfStockbasedCompensationLiability had a mix of decimals attribute values: -3 0. Element us-gaap_DebtInstrumentFaceAmount had a mix of decimals attribute values: -6 -5. Element us-gaap_DebtInstrumentInterestRateStatedPercentage had a mix of decimals attribute values: 3 5. Element us-gaap_ForeignCurrencyTransactionGainLossBeforeTax had a mix of decimals attribute values: -3 0. Element us-gaap_LongTermPurchaseCommitmentAmount had a mix of decimals attribute values: -5 0. Element us-gaap_ProceedsFromIssuanceOfDebt had a mix of decimals attribute values: -5 -3. 'Monetary' elements on report '004 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)' had a mix of different decimal attribute values. 'Monetary' elements on report '039 - Disclosure - Note 9 - Promissory Notes (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '048 - Disclosure - Note 13 - Purchase Commitments (Details)' had a mix of different decimal attribute values. Process Flow-Through: 001 - Statement - Condensed Consolidated Balance Sheets (Unaudited) Process Flow-Through: Removing column 'Jun. 30, 2013' Process Flow-Through: Removing column 'Dec. 31, 2012' Process Flow-Through: 002 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parentheticals) Process Flow-Through: 003 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) Process Flow-Through: 004 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Process Flow-Through: Removing column '3 Months Ended Jun. 30, 2014' sphs-20140630.xml sphs-20140630.xsd sphs-20140630_cal.xml sphs-20140630_def.xml sphs-20140630_lab.xml sphs-20140630_pre.xml true true